Navigation Links
Strand Diagnostics appoints new President

INDIANAPOLIS, Jan. 23, 2013 /PRNewswire/ -- Strand Diagnostics, LLC, maker of the know error® system, announced today the appointment of Laura Beggrow as President. She was recruited by Strand Diagnostics to drive the sales and marketing efforts of the company.

(Logo: )

"We are very excited about adding Laura to our team," said Strand Diagnostics CEO, Ted Schenberg . "We expect that her experience in building out large-scale sales organizations, and her track record of driving growth in early-stage molecular diagnostics companies will help accelerate adoption of the know error® system as the new standard of care."

Prior to joining Strand Diagnostics, Beggrow served as Vice President of U.S. Sales and Marketing at Genomic Health. During her tenure, she was responsible for commercializing the company's groundbreaking Oncotype DX products in the breast and colon cancer markets, growing sales of the Oncotype DX test from $10 million to more than $200 million per year.

"Laura's background is a perfect fit for where we are as a company," said Schenberg. "Her experience in commercializing molecular diagnostic testing for breast and prostate cancers will be a tremendous asset as we look to grow adoption of the know error® system."

"I am extremely excited to join Strand Diagnostics," said Beggrow. "They have developed some very compelling products in a short period of time and established a solid foundation on which to build. Specimen provenance is an under-appreciated aspect of the diagnostic cycle, with as many as 3.5 percent of biopsies in certain clinical settings resulting in a diagnosis complicated by undetected specimen switches or contaminations. The know error® system gives healthcare providers a tool to ensure that the right diagnosis is assigned to the right patient at the right time and the right cost – and all of this begins with the right specimen. I look forward to working with this talented and dedicated team to eliminate diagnostic mistakes due to undetected provenance errors."

The know error® system compares the DNA profile of a biopsy specimen to the DNA profile of a reference sample taken via cheek swab. This process safeguards patients from diagnostic and treatment errors that may occur due to undetected switches or contamination of biopsy specimens during the complex diagnostic testing cycle for cancer.

About Strand Diagnostics   
As a comprehensive provider of DNA testing services, Strand Diagnostics has a strong track record of using cutting-edge technology to solve complex problems in the criminal justice system and life sciences sector. The company's forensic division supports law enforcement agencies with forensic DNA identity testing services. Strand Diagnostics' healthcare division developed and markets the know error® system, which is used by physicians and laboratories to confirm specimen provenance as an integral component of the diagnostic testing cycle for cancer, ensuring patients are always matched with the appropriate diagnosis.

Mike Harmon  
Strand Diagnostics / Know Error   
888-9BIOPSY (924-6779) x114   

Kirsten Fallon
Schwartz MSL     

SOURCE Strand Diagnostics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Trovagene and Strand Life Sciences Agree to Validate and Commercialize Urine-Based HPV Test in India and South Asia
2. Isis Pharmaceuticals Demonstrates The Potential Of Single-Stranded RNA-Like Antisense Technology To Activate The RNAi Pathway
4. Johnson & Johnson Presents Growth Strategies for Medical Devices & Diagnostics Segment
5. Roche Diagnostics Named to FORTUNE magazines 2013 list of "100 Best Companies to Work For"
6. MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
7. Cardiology Point of Care Diagnostics: Products, players & outlook to 2017
8. The Complete Guide to Companion Diagnostics: Market Environment Products and Companies
9. Increasing Prevalence of Heart Disease Drives Growth of Cardiac Biomarkers Diagnostics Market, Says Frost & Sullivan
10. MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2012 Financial Results on Wednesday, December 19, 2012
11. Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
Post Your Comments:
(Date:11/30/2015)... 30, 2015  IBA Molecular North America, Inc. (IBAMNA), ... radiopharmaceuticals, announced that as of January 1, 2016, it ... The decision to rebrand the company reflects a refined ... as its close relationship with Zevacor Molecular.  Both IBAMNA ... Science (IHS). Peter Burke , Vice ...
(Date:11/30/2015)... , November 30, 2015 North ... and is expected to grow at a CAGR of 7.6% from ... was valued at USD 135.6 million in 2014, and is expected ... --> According to the new Market Research Report "North ... non-invasive), By End User (Hospitals, ambulatory care, others) - Analysis And ...
(Date:11/30/2015)... , Nov. 30, 2015  Kevin Smith ... Sensium Healthcare, a global pioneer in wireless monitoring ... Boston, MA , Mr. Smith will ... Sensium,s global commercial strategy.  He will also directly ... to build clinical evidence for SensiumVitals, the first ...
Breaking Medicine Technology:
(Date:11/30/2015)... , ... November 30, 2015 , ... At Grand Dental ... and convenient setting. , When you have dental problems, you need to turn to ... can effectively diagnose and treat your needs, a friendly dentist who counsels you on ...
(Date:11/30/2015)... ... , ... Using a combination of two blood sugar tests rather than a ... a new study by researchers at the School of Public Health at Georgia State ... of Blood Glucose Tests ,” published in Frontiers in Public Health, the researchers noted ...
(Date:11/30/2015)... ... November 30, 2015 , ... Newly ... out of Glen Ridge, NJ. He has both advanced training and considerable ... He is also an expert in cosmetic dentistry. He is an active ...
(Date:11/30/2015)... ... 2015 , ... International telepathology consultations can significantly improve patient ... Diagnostics researchers. Their review of more than 1,500 pathology cases submitted electronically ... significantly altered treatment plans for more than half of the cases in which ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ”Dying Words: The ... be released on December 1, 2015, to coincide with World AIDS Day. The multi-media ... journalist who covered the AIDS epidemic as he was dying of the disease. , ...
Breaking Medicine News(10 mins):